FDA Authorizes Autonomous AI for Portable Diabetic Retinopathy Screening

AEYE Health receives clearance for the first artificial intelligence solution to allow fully autonomous screening for diabetic retinopathy using a portable device.

Related Keywords

New York ,United States ,Optomed Aurora ,Zack Dvey Aharon ,Tsontchoa Ianchulev ,Healtha Aeye Health ,Drug Administration ,Health On ,New York Eye ,Mount Sinai ,